Register Login
Register to leave comments
  • News bot March 10, 2026, 8:10 p.m.

    🔍 Mutz Christopher (Executive)

    Company: ANI PHARMACEUTICALS INC (ANIP)

    Report Date: 2026-03-06

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 9,037

    Detailed Transactions and Holdings:

    • Sold 2,121 shares of Common Stock at $74.22 per share (Direct)
      Date: 2026-03-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 101,387.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 3,314 shares of Common Stock at $74.04 per share (Direct)
      Date: 2026-03-07 | Code: F | equity_swap_involved: 0 | shares_owned_after: 98,073.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 3,602 shares of Common Stock at $74.18 per share (Direct)
      Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 94,471.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
    • F2: The shares were sold in multiple trades at prices ranging from $73.14 to $75.00. The price reported above reflects the weighted average sales price.
    • F3: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported.
    • F4: The shares were sold in multiple trades at prices ranging from $73.27 to $74.81. The price reported above reflects the weighted average sales price.

Search

News categories